| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1159/000060522 |
| P698 | PubMed publication ID | 11791466 |
| P2093 | author name string | Maini RN | |
| Feldmann M | |||
| Brennan FM | |||
| Foxwell BM | |||
| P921 | main subject | TNF | Q18032037 |
| rheumatoid arthritis | Q187255 | ||
| P304 | page(s) | 188-199 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Current directions in autoimmunity | Q26842607 |
| P1476 | title | The role of TNF alpha and IL-1 in rheumatoid arthritis | |
| P478 | volume | 3 |
| Q36651396 | Amelioration of collagen-induced arthritis in female dark agouti rats by glucosamine treatment |
| Q28245637 | Anti-IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss |
| Q55259964 | Autoantibodies to Chemokines and Cytokines Participate in the Regulation of Cancer and Autoimmunity. |
| Q84395714 | Blood-derived anti-inflammatory protein solution blocks the effect of IL-1β on human macrophages in vitro |
| Q36337258 | Current imaging strategies in rheumatoid arthritis |
| Q47429306 | Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies |
| Q37207010 | Developments in the clinical understanding of rheumatoid arthritis |
| Q41811961 | Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RA. |
| Q93190686 | Dose-Dependent Efficacy of Gold Clusters on Rheumatoid Arthritis Therapy |
| Q36427163 | Effect of Bizhongxiao decoction and its dismantled formulae on IL-1 and TNF levels in collagen-induced arthritis in rat synovial joints |
| Q37710041 | Effect of γ-tocotrienol in counteracting oxidative stress and joint damage in collagen-induced arthritis in rats. |
| Q35605942 | Effects of PVA coated nanoparticles on human immune cells |
| Q34572691 | Effects of resveratrol in inflammatory arthritis |
| Q24804396 | Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats |
| Q36013833 | Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy |
| Q59536301 | Etanercept in the treatment of rheumatoid arthritis: clinical follow-up over one year by ultrasonography |
| Q36067286 | Exogenous tumour necrosis factor alpha induces suppression of autoimmune arthritis |
| Q51835921 | Expression and characterization of the chemokine receptor CCR2B from rhesus monkey. |
| Q44225233 | Fenfluramine-induced immunosuppression: an in vivo analysis |
| Q37214931 | Gene polymorphisms and pharmacogenetics in rheumatoid arthritis |
| Q64084998 | Gold Clusters Prevent Inflammation-Induced Bone Erosion through Inhibiting the Activation of NF-κB Pathway |
| Q34460609 | Immunomodulation of Autoimmune Arthritis by Herbal CAM |
| Q34086947 | Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjögren's syndrome |
| Q39665813 | Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis |
| Q40840871 | Intraarticular Administration of Dexamethasone after Mesenchymal Stem Cells Implantation Does Not Improve Significantly the Treatment of Preestablished Full-Thickness Chondral Defect in a Rabbit Model |
| Q34927462 | Low-level laser therapy attenuates the myeloperoxidase activity and inflammatory mediator generation in lung inflammation induced by gut ischemia and reperfusion: a dose-response study |
| Q46872914 | Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide |
| Q51455516 | Modulation of C-reactive protein and tumour necrosis factor-α in collagen-induced arthritis in Dark Agouti rats: impact of collagen concentration on severity of arthritis. |
| Q36997280 | Neuroendocrine-immune correlates of circadian physiology: studies in experimental models of arthritis, ethanol feeding, aging, social isolation, and calorie restriction. |
| Q64235920 | New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis |
| Q36849874 | New therapies for treatment of rheumatoid arthritis |
| Q34896412 | Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice |
| Q46508793 | Pharmacokinetic-Pharmacodynamic Modeling of Apratastat: A Population-Based Approach |
| Q42100340 | Pharmacological analysis for mechanisms of GPI-80 release from tumour necrosis factor-alpha-stimulated human neutrophils |
| Q47446256 | Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo |
| Q39414974 | Signaling transduction analysis in gingival epithelial cells after infection with Aggregatibacter actinomycetemcomitans. |
| Q33906269 | Ssu72 attenuates autoimmune arthritis via targeting of STAT3 signaling and Th17 activation |
| Q34363307 | Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population. |
| Q35117732 | TNF-α and TNF-β Gene Polymorphism in Saudi Rheumatoid Arthritis Patients |
| Q26773127 | The Role of Chemokines in Shaping the Balance Between CD4(+) T Cell Subsets and Its Therapeutic Implications in Autoimmune and Cancer Diseases |
| Q51343489 | The anti-arthritic and anti-oxidative effect of NBD (6-nitro-1,3-benzodioxane) in adjuvant-induced arthritis (AIA) in rats. |
| Q37067708 | The anti-arthritic and immune-modulatory effects of NHAG: a novel glucosamine analogue in adjuvant-induced arthritis. |
| Q35153653 | The complement system as a therapeutic target in autoimmunity |
| Q44527564 | The investigation of synovial genomic targets of bucillamine with microarray technique. |
| Q36934993 | The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis |
| Q48029200 | The pathogenesis of rheumatoid arthritis: new insights from old clinical data? |
| Q35164732 | The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis |
| Q38210876 | The therapeutic potential of anti-interleukin-20 monoclonal antibody |
| Q42283198 | Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis. |
| Q26744033 | Therapeutic implications of autoantibodies in rheumatoid arthritis |
| Q34749703 | Tissue engineering: advances in in vitro cartilage generation |
| Q38285827 | Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy |
| Q27021391 | Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer |
| Q92615854 | Tumour necrosis factor gene polymorphisms in Egyptian patients with rheumatoid arthritis and their relation to disease activity and severity |
Search more.